WO2006018814A3 - Oral liquid suspensions of metaxalone - Google Patents

Oral liquid suspensions of metaxalone Download PDF

Info

Publication number
WO2006018814A3
WO2006018814A3 PCT/IB2005/052705 IB2005052705W WO2006018814A3 WO 2006018814 A3 WO2006018814 A3 WO 2006018814A3 IB 2005052705 W IB2005052705 W IB 2005052705W WO 2006018814 A3 WO2006018814 A3 WO 2006018814A3
Authority
WO
WIPO (PCT)
Prior art keywords
metaxalone
oral liquid
liquid suspensions
suspensions
processes
Prior art date
Application number
PCT/IB2005/052705
Other languages
French (fr)
Other versions
WO2006018814A2 (en
Inventor
Ajay Kumar Singla
Malluru Subba Rao
Tausif Monif
Original Assignee
Ranbaxy Lab Ltd
Ajay Kumar Singla
Malluru Subba Rao
Tausif Monif
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd, Ajay Kumar Singla, Malluru Subba Rao, Tausif Monif filed Critical Ranbaxy Lab Ltd
Publication of WO2006018814A2 publication Critical patent/WO2006018814A2/en
Publication of WO2006018814A3 publication Critical patent/WO2006018814A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to liquid oral suspension dosage forms of metaxalone and processes for their preparation.
PCT/IB2005/052705 2004-08-16 2005-08-16 Oral liquid suspensions of metaxalone WO2006018814A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1509DE2004 2004-08-16
IN1509/DEL/2004 2004-08-16

Publications (2)

Publication Number Publication Date
WO2006018814A2 WO2006018814A2 (en) 2006-02-23
WO2006018814A3 true WO2006018814A3 (en) 2006-08-24

Family

ID=35636902

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/052705 WO2006018814A2 (en) 2004-08-16 2005-08-16 Oral liquid suspensions of metaxalone

Country Status (1)

Country Link
WO (1) WO2006018814A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2012DN02379A (en) * 2009-09-10 2015-08-21 Bial Portela & C A Sa
IT1401086B1 (en) * 2010-07-19 2013-07-12 Farmalip S R L SWEETENER.
ES2556985T3 (en) 2011-01-11 2016-01-21 Capsugel Belgium Nv New hard capsules comprising pululane
ITUB20155193A1 (en) * 2015-11-03 2017-05-03 Italfarmaco Spa Physically and chemically stable oral Givinostat suspensions
US20190282500A1 (en) 2016-09-09 2019-09-19 Cutispharma, Inc. Suspensions and diluents for metronidazole and baclofen
AU2018253392B2 (en) 2017-04-14 2023-11-02 Capsugel Belgium Nv Process for making pullulan
JP2020516653A (en) 2017-04-14 2020-06-11 カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップＣａｐｓｕｇｅｌ Ｂｅｌｇｉｕｍ ＮＶ Pullulan capsule

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993767A (en) * 1975-11-18 1976-11-23 A. H. Robins Company, Incorporated Compositions to suppress gastric bleeding in indomethacin and phenylbutazone therapy
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
WO2004066981A1 (en) * 2003-01-29 2004-08-12 Sun Pharmaceutical Industries Limited Oral controlled release pharmaceutical composition containing metaxalone as active agent
WO2005016310A1 (en) * 2003-08-08 2005-02-24 Elan Pharma International Ltd. Novel metaxalone compositions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993767A (en) * 1975-11-18 1976-11-23 A. H. Robins Company, Incorporated Compositions to suppress gastric bleeding in indomethacin and phenylbutazone therapy
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
WO2004066981A1 (en) * 2003-01-29 2004-08-12 Sun Pharmaceutical Industries Limited Oral controlled release pharmaceutical composition containing metaxalone as active agent
WO2005016310A1 (en) * 2003-08-08 2005-02-24 Elan Pharma International Ltd. Novel metaxalone compositions

Also Published As

Publication number Publication date
WO2006018814A2 (en) 2006-02-23

Similar Documents

Publication Publication Date Title
WO2006124748A3 (en) Multicyclic compounds and methods of their use
IL178730A0 (en) New pharmaceutical compositions for the treatment of sexual disorders ii
ZA200606804B (en) Pharmaceutical composition for treatment of immunological disorders
EP2213684A3 (en) Nogo-a antibodies for the treatment of Alzheimer disease
WO2007051062A3 (en) Substituted dihydropyridines and methods of use
NO20070753L (en) Process for the preparation of dihydropteridinones
EP1893216A4 (en) Methods and compositions for the treatment of ocular disorders
WO2007056221A3 (en) Aminopyrimidines useful as kinase inhibitors
IL176486A0 (en) Azabenzofuran substituted thioureas as inhibtitors of viral replication
EP1748765A4 (en) Pharmaceutical suspension composition
WO2006015035A8 (en) Useful compounds for hpv infection
WO2006018814A3 (en) Oral liquid suspensions of metaxalone
ZA200702523B (en) Process for the purification of 1,4-butanediol
WO2008076392A3 (en) Compounds useful as protein kinase inhibitors
HK1166983A1 (en) Solid forms comprising compounds for the treatment of diseases or disorders, compositions thereof, and use therewith
WO2008116139A3 (en) N-heterocyclic compounds useful as inhibitors of janus kinases
HK1098486A1 (en) Aqueous suspensions of ciclesonide for nebulisation
EP1838906A4 (en) Preparation of suspensions
WO2008079521A3 (en) Tricyclic heteroaryl compounds useful as inhibitors of janus kinase
PL1940409T3 (en) Novel pharmaceutical combinations for the treatment of respiratory disorders
ZA200800926B (en) Oral suspension of prednisolone acetate
EP1814535A4 (en) Nitrosated and nitrosylated compounds, compositions and methods for the treatment of ophthalmic disorders
WO2007025146A3 (en) Balsalazide formulations and manufacture and use thereof
PL1846376T3 (en) Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide
SI1737820T1 (en) Asymmetric hydrogenation process useful for the preparation of cycloalkanoindole derivatives

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase